Gallium-68-MLN-6907

N/A

Report date: 2025/11/20 16:02:30

NME

Base Information

Drug NameGallium-68-MLN-6907

Drug Alias Name68Ga-MLN-6907[68Ga]MLN-6907Gallium-68-MLN-6907[68Ga]MLN6907

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsHeat-stable enterotoxin receptor

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMillennium Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMillennium Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A